The SynapTau team is thrilled to announce the publication of our collaborative work. This has been an incredible partnership, and we are delighted to share our findings in the journal Life Science Alliance! In this paper, we demonstrated that parenchymal border macrophages (PBMs) function impedes tau pathology and tau-mediated neurodegeneration, while tau pathology promotes PBM dysfunction associated with impaired CSF flow. Our results identify PBMs as novel cellular regulators of tau pathology and tau-mediated neurodegeneration.

The GlioME Team has new publication out in International Journal of Molecular Sciences as part of the Special Issue « Emerging Therapies for Glioblastoma ». This article deals with one of the team’s key issues, the gangliosides recognized by the A2B5 antibody and used as biomarker of cancer stem cells (CSC) in glioblastoma human brain tumours.

On July 6, 5 INP members took part in the first Ma Terre en 180' workshop organized by Louise Greetham (Team 6/SCENT) and Santiago Rivera (Team 1). MT 180' is the 1st collaborative workshop from the academic world to build scenarios for reducing carbon footprint within a research laboratory. Congratulations to Fanny (aka Maggie), Laure (aka Zara), Theresa (aka Claire), Géraldine (aka David) and Ivan (aka Benjamin) for their participation and commitment.

Since the first event in Marseille in 2013, initiated by François Devred and Stéphane Honoré, the French microtubule network has been organizing colloquia bringing together researchers, post-docs and students from more than 34 laboratories, every 2 years in a different city. After Grenoble (2015), Versailles (2017), and Rennes (2019), the fifth edition of the congress of french scientists working on microtubules took place on June 29 and 30, 2023 in Montpellier. 

The GlioME team was delighted to take part in the tumoroids workshop at the summerschool organized by the Institute of Cancer and Immunology. For one day, the team welcomed 8 international students to introduce them to the preparation of human glioblastoma tumoroids. A day rich in scientific and human exchanges.